Reversal by guanethidine of abnormal oral glucose tolerance in thyrotoxicosis.

K. Woeber,R. Arky,L. Braverman

DOI: https://doi.org/10.1016/S0140-6736(66)91575-3

IF: 202.731

1966-04-23

The Lancet

Abstract:

What problem does this paper attempt to address?

[Retracted] MicroRNA‑18b Inhibits the Growth of Malignant Melanoma Via Inhibition of HIF‑1α‑mediated Glycolysis

Yao Chen,Ziqing Zhang,Chunxiong Luo,Zizi Chen,Jianda Zhou

DOI: https://doi.org/10.3892/or.2021.8161

2021-01-01

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the flow cytometric data shown in Fig. 3, and western blotting assay data shown in Fig. 6F, were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive any reply. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Reports 36: 471‑479, 2016; DOI: 10.3892/or.2016.4824]
RETRACTION: MicroRNA-155 enhances the activation of Wnt/beta-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1 (Retraction of Vol 13, Pg 2221, 2016)

Ying-Chun Wan,Tao Li,Yang-Dong Han,Hai-Yan Zhang,Hai Lin,Bin Zhang

DOI: https://doi.org/10.3892/mmr.2022.12597

IF: 3.423

2022-01-01

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the western blot assay data shown in Figs. 1C and 6A were strikingly similar to data appearing in different form in another article written by different authors. Owing to the fact that the contentious data in the above article were already under consideration for publication prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in 13: 2221‑2228, 2016; DOI: 10.3892/mmr.2016.4788].
RETRACTION: The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma

DOI: https://doi.org/10.1002/1878-0261.13677

Abstract:Tang, Y. H., He, G. L., Huang, S. Z., Zhong, K. B., Liao, H., Cai, L., Gao, Y., Peng, Z. W., & Fu, S. J. (2019), The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma. Mol Oncol, 13(5): 1296-1310. https://doi.org/10.1002/1878-0261.12487. The above article, published online on 11 April 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Kevin Ryan, FEBS Press, and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed image duplication between figure 2D of this manuscript and figure 4G of an earlier publication by different authors [1]. The authors provided images of the trays of cell colonies which match the panels in figure 2, but did not provide a compelling explanation for the image duplication with the earlier publication [1]. Therefore, the editors consider the conclusions of the study to be substantially compromised and are retracting the article. The authors do not agree with the retraction. Reference [1] Zeng JD, Zhang N, Zhao GJ, Xu LX, Yang Y, Xu XY, Chen MK, Wang HY, Zheng SX, Li XX. (2018) MT1G is Silenced by DNA Methylation and Contributes to the Pathogenesis of Hepatocellular Carcinoma. J Cancer, 9(16): 2807-2816. https://doi.org/10.7150/jca.25680.
RETRACTION: miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer (Retraction of Vol 234, Pg 23596, 2020)

Fengming Yang,Chuchu Shao,Ke Wei,Xinming Jing,Zhiqiang Qin,Yuenian Shi,Yongqian Shu,Hua Shen

DOI: https://doi.org/10.1002/jcp.30701

2022-01-01

Journal of Cellular Physiology

Abstract:Retraction: "miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer," by Fengming Yang, Chuchu Shao, Ke Wei, Xinming Jing, Zhiqiang Qin, Yuenian Shi, Yongqian Shu, and Hua Shen, J Cell Physiol. 2020; 23596-23607: The above article, published online on 24 June 2019 in Wiley Online Library (), has been retracted by agreement between the authors, the journal's Editor in Chief, Prof. Dr. Gregg Fields, and Wiley Periodicals LLC. The retraction has been agreed following an investigation based on public allegations, and after the authors asked to correct the article. Several flaws and inconsistencies between results presented and experimental methods described were found, and so the editors consider the conclusions of this article to be invalid.
Retracted: LINC00518 Promotes Cell Malignant Behaviors via Influencing EIF4A3-Mediated mRNA Stability of MITF in Melanoma

BioMed Research International

DOI: https://doi.org/10.1155/2024/9846817

2024-03-21

BioMed Research International

Abstract:This article has been retracted by Hindawi following an investigation undertaken by the publisher [1]. This investigation has uncovered evidence of one or more of the following indicators of systematic manipulation of the publication process: (1) Discrepancies in scope (2) Discrepancies in the description of the research reported (3) Discrepancies between the availability of data and the research described (4) Inappropriate citations (5) Incoherent, meaningless and/or irrelevant content included in the article (6) Manipulated or compromised peer review

biotechnology & applied microbiology,medicine, research & experimental
Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats.

B. Vadiraja,Nilesh W. Gaikwad,K. Madyastha,K. Madyastha

DOI: https://doi.org/10.1006/BBRC.1998.9149

1998-08-19

Abstract:Effect of C-phycocyanin (from Spirulina platensis) pretreatment on carbontetrachloride and R-(+)-pulegone-induced hepatotoxicity in rats was studied. Intraperitoneal (i.p.) administration (200 mg/kg) of a single dose of phycocyanin to rats, one or three hours prior to R-(+)-pulegone (250 mg/kg) or carbontetrachloride (0.6 ml/kg) challenge, significantly reduced the hepatotoxicity caused by these chemicals. For instance, serum glutamate pyruvate transaminase (SGPT) activity was almost equal to control values. The losses of microsomal cytochrome P450, glucose-6-phosphatase and aminopyrine-N-demethylase were significantly reduced, suggesting that phycocyanin provides protection to liver enzymes. It was noticed that the level of menthofuran, the proximate toxin of R-(+)-pulegone was nearly 70% more in the urine samples collected from rats treated with R-(+)-pulegone alone than rats treated with the combination of phycocyanin and R-(+)-pulegone. The possible mechanism involved in the hepatoprotection is discussed.
[Retracted] Serum miR‐338‐5p has potential for use as a tumor marker for retinoblastoma

Peng Zhou,Xuemin Li

DOI: https://doi.org/10.3892/ol.2024.14347

2024-03-21

Oncology Letters

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the Transwell cell migration and invasion assay data shown in Fig. 4A and B on p. 312 had already appeared in several previously published articles written by different authors at different research institutes. In addition, the second (more senior) author listed on the paper (Xuemin Li), who was also included as the author for correspondence, claimed that he had no knowledge of this paper's submission, and requested that it be withdrawn from the publication. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Letters , the Editor has agreed with the request that this paper should be retracted from the Journal. The Editor apologizes to the readership for any inconvenience caused. [Oncology Letters 18: 307‐313, 2019; DOI: 10.3892/ol.2019.10331]

oncology
RETRACTED ARTICLE: Mir-135 Promotes Proliferation and Stemness of Oesophageal Squamous Cell Carcinoma by Targeting RERG

Yan Zhang,Shuang Ren,Fengfeng Yuan,Kaishang Zhang,Yingying Fan,Shusen Zheng,Zhen Gao,Jia Zhao,Maikun Teng,Zhao Song,Anquan Shang,Xiangnan Li,Ying Jin

DOI: https://doi.org/10.6084/m9.figshare.7039877

2020-01-01

Abstract:We, the Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article: Yan Zhang, Shuang Ren, Fengfeng Yuan, Kaishang Zhang, Yingying Fan, Shaozhong Zheng, Zhen Gao, Jia Zhao, Teng Mu, Song Zhao, AnQuan Shang, Xiangnan Li and Ying Jie. (2018). miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG. Artificial Cells, Nanomedicine, and Biotechnology. 46:S2, S1210–S1219, DOI: 10.1080/21691401.2018.1483379 Since publication, the authors noticed errors in their data calculation. As this error directly impacts the reported results and conclusions the authors alerted the issue to the Editor and Publisher and all have agreed to retract the article to ensure correction of the scholarly record. We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
RETRACTION: SLC1A3 Promotes Gastric Cancer Progression via the PI3K/AKT Signalling Pathway

DOI: https://doi.org/10.1111/jcmm.18568

Abstract:Xu L, Chen J, Jia L, Chen X, Moumin FA, Cai J. SLC1A3 Promotes Gastric Cancer Progression via the PI3K/AKT Signalling Pathway. Journal of Cellular and Molecular Medicine 2020;24(24):14392-14404. https://doi.org/10.1111/jcmm.16060 The above article, published online on 3 November 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan N. Constantinescu; the Foundation for Cellular and Molecular Medicine; and John Wiley & Sons Ltd. The retraction has been agreed due to concerns raised by third parties. Specifically, image elements of Figure 6G were found to have been previously published in a different scientific context.1 The corresponding author stated that a third-party company partially generated the data presented in the article and suggested there may have been mishandling of the data. Additionally, the article mentions use of the unverifiable/unknown cell line GSE-1 and presents results from the cell line MKN-28, reported as misidentified by the Japanese Collection of Research Bioresources (JCRB) Cell Bank of the National Institutes of Biomedical Innovation, Health and Nutrition (https://cellbank.nibiohn.go.jp/). Therefore, the editors consider the conclusions of this article to be invalid. The authors have been informed of the decision of retraction. [1] Pang X, Li R, Shi D, Pan X, Ma C, Zhang G, Mu C, Chen W. Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells. Oncol Lett. 2017;14(6):8028-8034. https://doi.org/10.1111/jcmm.16060.
[Retracted] MicroRNA‐329‐3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer

Wenfeng Li,Jingjing Liang,Zhechao Zhang,Hongyan Lou,Liang Zhao,Yunsheng Xu,Rongying Ou

DOI: https://doi.org/10.3892/or.2024.8745

2024-04-30

Oncology Reports

Abstract:Following the publication of the above article, a concerned reader drew to the Editor's attention that certain of the Transwell cell migration and invasion assay data featured in Figs. 5C and 6C were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had already been published elsewhere prior to the submission of this paper to Oncology Reports , or were submitted for consideration for publication at around the same time. In view of the fact that certain of these data had already apparently been published prior to the submission of this article for publication, the Editor of Oncology Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 37: 2743‐2750, 2017; DOI: 10.3892/or.2017.5555]

oncology
[Retracted] miR‐660‐5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma

Tao He,Peijie Chen,Lu Jin,Jia Hu,Yifan Li,Liang Zhou,Shangqi Yang,Xiangming Mao,Yaoting Gui,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/mmr.2024.13210

IF: 3.423

2024-03-28

Molecular Medicine Reports

Abstract:Following the publication of the above article, the authors contacted the Editorial Office to explain that a couple of errors concerning data handling/labelling had been made, firstly during the preparation of the representative images in Fig. 3B, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' at 0 h experiment, and secondly in Fig. 5A, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' experiment. The authors requested that a corrigendum be published to take account of the errors that were made during the preparation of this figure. Subsequently, an independent investigation of the published data was undertaken by the Editorial Office, which revealed that the 'Inhibitor' data panel in Fig. 6A and the 'Mimic NC' data panel in Fig. 6B were also overlapping, such that these data were likely to have been derived from the same original source, even though these data panels were intended to have shown the results from differently performed experiments. The Editor of Molecular Medicine Reports has considered the authors' request to publish a corrigendum, but given the number of overlapping data panels that have been identified and the number of figures that would be in need of correction, the Editor has decided to decline the authors' request to publish a corrigendum on account of an overall lack of confidence in the presented data, and instead has determined that the paper should be retracted. Upon receiving this news from the Editor, the authors accepted the Editor's decision. The Editor apologizes to the readership of the Journal for any inconvenience caused. [Molecular Medicine Reports 17: 2051‐2060, 2018; DOI: 10.3892/mmr.2017.8052]

oncology,medicine, research & experimental
Retraction Note: Regulation of miRNAs on c-met protein expression in ovarian cancer and its implication

H Liu,S-R Li,Q Si

DOI: https://doi.org/10.26355/eurrev_202407_36518

Abstract:The article "Regulation of miRNAs on c-met protein expression in ovarian cancer and its implication", by H. Liu, S.-R. Li, Q. Si, published in Eur Rev Med Pharmacol Sci 2017; 21 (15): 3353-3359-PMID: 28829508 has been retracted by the Editor in Chief. Following some concerns raised on PubPeer regarding a possible manipulation in Figure 5 (link: https://pubpeer.com/publications/7B6E6E6679990661654EBCAF472921), the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. The authors were informed about the journal's investigation but remained unresponsive and have not provided the manuscript's raw data. The journal's investigation revealed a figure overlap between panels pcDNA3.1-EGFP and pcDNA3.1-EGFP-204-up in Figure 5. Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/13200.
In memoriam George Tarjan, M.D. 1912-1991.

R. Pasnau,H. Work

DOI: https://doi.org/10.1176/AJP.150.5.691

IF: 17.7

1993-05-01

American Journal of Psychiatry

Abstract:
[Retracted] miR‐143‐5p suppresses breast cancer progression by targeting the HIF‐1α‐related GLUT1 pathway

Jia Xu,Xi Li,Purong Zhang,Jie Luo,Exian Mou,Shiwei Liu

DOI: https://doi.org/10.3892/ol.2024.14444

2024-05-15

Oncology Letters

Abstract:Following the publication of this article, a concerned reader has drawn to the attention of the Editorial Office that certain of the colony‐formation assay data shown in Fig. 6F on p. 9 had already been published in the following paper, written by different authors at different research institutes: Wu X, Cui F, Chen Y, Zhu Y and Liu F: Long non‐coding RNA LOXL1‐AS1 enhances colorectal cancer proliferation, migration and nvasion through miR‐708‐5p/CD44‐EGFR axis. Onco Targets Ther 13: 7615‐7627, 2020. Owing to the fact that the contentious data in Fig. 6F of the above article had already been published prior to its submission to Oncology Letters , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Letters 23: 147, 2022; DOI: 10.3892/ol.2022.13268]

oncology
RETRACTION: Selection for TRAIL Resistance Results in Melanoma Cells with High Proliferative Potential

DOI: https://doi.org/10.1002/1873-3468.15028

Abstract:J. J. Wu, X. D. Zhang, S. Gillespie, and P. Hersey, "Selection for TRAIL Resistance Results in Melanoma Cells with High Proliferative Potential," FEBS Letters 579, no. 9 (2005): 1940-1944, https://doi.org/10.1016/j.febslet.2005.02.041. The above article, published online on February 25, 2005, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Michael Brunner; FEBS Press; and John Wiley and Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed inappropriate duplications of image sections within the article (Fig. 2A, 3A-C, 4A-B) depicting different experimental conditions. The authors were unable to provide a satisfactory explanation and due to the elapsed time the raw data was not available. Given the extent of the identified issues, the editors have lost confidence in the data presented and the article's conclusions can no longer be considered reliable.
[Retracted] MicroRNA‐212 inhibits colorectal cancer cell viability and invasion by directly targeting PIK3R3

Jian Zhang,Yongkang Zhang,Xiaoyun Li,Hongbo Wang,Quan Li,Xiaofeng Liao

DOI: https://doi.org/10.3892/mmr.2023.13025

IF: 3.423

2023-05-30

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the western blotting data shown in Fig. 4A were strikingly similar to data appearing in different form in other articles by different authors at different research institutes, several of which have been retracted. Owing to the fact that the contentious data in the above article were already under consideration for publication prior to its submission to <i>Molecular Medicine Reports</i>, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 16: 7864‑7872, 2017; DOI: 10.3892/mmr.2017.7552].

oncology,medicine, research & experimental
[Retracted] MicroRNA‐21 increases cell viability and suppresses cellular apoptosis in non‐small cell lung cancer by regulating the PI3K/Akt signaling pathway

Tao Wang,Zhenyu Cai,Guolin Hong,Gangsen Zheng,Yu Huang,Shun Zhang,Jinhua Dai

DOI: https://doi.org/10.3892/mmr.2020.11758

IF: 3.423

2020-12-04

Molecular Medicine Reports

Abstract:Following the publication of this paper, the authors have contacted the Editorial Office to request that their article be retracted. The reason for this retraction is an inability to be able to replicate certain of their previous results, and also disagreements among the authors as to the interpretation of some of the data. Following further discussion, all authors and the Editor of Molecular Medicine Reports are in agreement that the paper should be retracted; moreover, the authors apologize to the readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 16: 6506‑6511, 2017; DOI: 10.3892/mmr.2017.7440].

oncology,medicine, research & experimental
[Retracted] AdipoR1‐mediated miR‐3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway

Xiangming Liu,Jinglong Chen,Jinqian Zhang

DOI: https://doi.org/10.3892/or.2024.8697

2024-01-06

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the western blotting data shown in Figs. 3B and 9, and the migration assay data shown in Fig. 6C, were strikingly similar to data that had already appeared in other publications written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 37: 3387‐3396, 2017; DOI: 10.3892/or.2017.5589]

oncology
[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

Xiaoping Sun,Min Xu,Haiyan Liu,Kunxiu Ming

DOI: https://doi.org/10.3892/mmr.2024.13237

IF: 3.423

2024-05-10

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell migration and invasion assay data shown in Figs. 2C and 4C were strikingly similar to data that had already been published in different form in another article written by different authors at a different research institute [Yang S, Zhang Y, Zhao X, Wang J and Shang J: microRNA‐361 targets Wilms' tumor 1 to inhibit the growth, migration and invasion of non‐small‐cell lung cancer cells. Mol Med Rep 14: 5415‐5421, 2016]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 16: 3557‐3564, 2017; DOI: 10.3892/mmr.2017.7000]

oncology,medicine, research & experimental
RETRACTION: Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation

DOI: https://doi.org/10.1111/cas.16312

2024-08-21

Abstract:C.-W. Li, J. Zheng, G.-Q. Deng, Y.-G. Zhang, Y. Du and H.-Y. Jiang, "Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation," Cancer Science 113, no. 5 (2022): 1652-1668, https://doi.org/10.1111/cas.15337. The above article, published online on 16 March 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley & Sons Australia, Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed that images of pathological results were duplicated across other articles in a different scientific context. The authors acknowledge the duplication of the images and apologise for the errors. Despite the authors providing all original data and reconducting the animal pathology experiments, given the extent and nature of duplications found, the editors consider the results and conclusion of this article to be invalid.

Reversal by guanethidine of abnormal oral glucose tolerance in thyrotoxicosis.

[Retracted] MicroRNA‑18b Inhibits the Growth of Malignant Melanoma Via Inhibition of HIF‑1α‑mediated Glycolysis

RETRACTION: MicroRNA-155 enhances the activation of Wnt/beta-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1 (Retraction of Vol 13, Pg 2221, 2016)

RETRACTION: The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma

RETRACTION: miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer (Retraction of Vol 234, Pg 23596, 2020)

Retracted: LINC00518 Promotes Cell Malignant Behaviors via Influencing EIF4A3-Mediated mRNA Stability of MITF in Melanoma

Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats.

[Retracted] Serum miR‐338‐5p has potential for use as a tumor marker for retinoblastoma

RETRACTED ARTICLE: Mir-135 Promotes Proliferation and Stemness of Oesophageal Squamous Cell Carcinoma by Targeting RERG

RETRACTION: SLC1A3 Promotes Gastric Cancer Progression via the PI3K/AKT Signalling Pathway

[Retracted] MicroRNA‐329‐3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer

[Retracted] miR‐660‐5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma

Retraction Note: Regulation of miRNAs on c-met protein expression in ovarian cancer and its implication

In memoriam George Tarjan, M.D. 1912-1991.

[Retracted] miR‐143‐5p suppresses breast cancer progression by targeting the HIF‐1α‐related GLUT1 pathway

RETRACTION: Selection for TRAIL Resistance Results in Melanoma Cells with High Proliferative Potential

[Retracted] MicroRNA‐212 inhibits colorectal cancer cell viability and invasion by directly targeting PIK3R3

[Retracted] MicroRNA‐21 increases cell viability and suppresses cellular apoptosis in non‐small cell lung cancer by regulating the PI3K/Akt signaling pathway

[Retracted] AdipoR1‐mediated miR‐3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway

[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

RETRACTION: Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation